|
|
|
Insider
Information: |
Lawlor Augustine |
Relationship: |
Chief Operating Officer |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
3,659,632 |
|
Indirect Shares
|
2,634,390 |
|
|
Direct
Value |
$25,940 |
|
|
Indirect Value
|
$2,673,750 |
|
|
Total
Shares |
6,294,022 |
|
|
Total
Value |
$2,699,690 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
0.0%
|
-7.1%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Middlebrook Pharmaceuticals Corp |
MBRKQ |
10% Owner |
2003-10-22 |
3,629,973 |
2003-10-22 |
0 |
Premium* |
|
Human Genome Sciences Inc |
HGSI |
Director |
2012-07-30 |
0 |
|
0 |
Premium* |
|
Replidyne Inc |
RDYN |
Director |
2023-04-27 |
0 |
2023-04-27 |
0 |
Premium* |
|
Molecular Templates, Inc. |
MTEM |
10% Owner |
|
0 |
2008-08-29 |
1,470,588 |
Premium* |
|
Gyre Therapeutics |
GYRE |
Director |
2021-10-01 |
24,573 |
2021-10-01 |
24,215 |
Premium* |
|
Globeimmune Inc |
GBIM |
Director |
2016-02-22 |
0 |
2016-03-18 |
463,267 |
Premium* |
|
Leap Therapeutics, Inc. |
LPTX |
Chief Operating Officer |
2024-01-26 |
5,086 |
2024-01-26 |
676,320 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
81 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
HGSI |
Human Genome Sciences Inc |
Director |
|
2004-03-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,311 |
|
- |
|
MTEM |
Molecular Templates, Inc. |
10% Owner |
|
2008-08-29 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,470,588 |
|
- |
|
LPTX |
Leap Therapeutics, Inc. |
Chief Operating OfficerOfficer |
|
2017-01-20 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,477,902 |
|
- |
|
MBRKQ |
Middlebrook Pharmaceutica... |
10% Owner |
|
2003-10-22 |
4 |
A |
$0.00 |
$0 |
D/D |
3,629,973 |
3,629,973 |
|
- |
|
RDYN |
Replidyne Inc |
Director |
|
2006-07-03 |
4 |
A |
$0.00 |
$0 |
I/I |
3,869,796 |
4,212,628 |
|
- |
|
HGSI |
Human Genome Sciences Inc |
Director |
|
2007-07-11 |
4 |
A |
$0.00 |
$0 |
D/D |
611 |
2,022 |
0 |
- |
|
HGSI |
Human Genome Sciences Inc |
Director |
|
2007-10-10 |
4 |
A |
$10.02 |
$6,743 |
D/D |
673 |
2,695 |
0 |
- |
|
HGSI |
Human Genome Sciences Inc |
Director |
|
2008-01-11 |
4 |
A |
$11.62 |
$9,494 |
D/D |
817 |
3,512 |
0 |
- |
|
HGSI |
Human Genome Sciences Inc |
Director |
|
2008-04-11 |
4 |
A |
$6.50 |
$9,874 |
D/D |
1,519 |
5,031 |
0 |
- |
|
HGSI |
Human Genome Sciences Inc |
Director |
|
2008-07-11 |
4 |
A |
$5.79 |
$6,873 |
D/D |
1,187 |
6,218 |
0 |
- |
|
HGSI |
Human Genome Sciences Inc |
Director |
|
2008-10-10 |
4 |
A |
$3.71 |
$8,622 |
D/D |
2,324 |
8,542 |
0 |
- |
|
HGSI |
Human Genome Sciences Inc |
Director |
|
2009-01-10 |
4 |
A |
$1.88 |
$10,750 |
D/D |
5,718 |
14,160 |
0 |
- |
|
HGSI |
Human Genome Sciences Inc |
Director |
|
2009-04-10 |
4 |
A |
$0.87 |
$9,125 |
D/D |
10,488 |
24,648 |
0 |
- |
|
HGSI |
Human Genome Sciences Inc |
Director |
|
2009-07-10 |
4 |
A |
$2.53 |
$7,248 |
D/D |
2,865 |
27,513 |
0 |
- |
|
HGSI |
Human Genome Sciences Inc |
Director |
|
2009-10-12 |
4 |
A |
$18.50 |
$7,234 |
D/D |
391 |
27,904 |
0 |
- |
|
HGSI |
Human Genome Sciences Inc |
Director |
|
2010-01-11 |
4 |
A |
$30.82 |
$10,232 |
D/D |
332 |
28,236 |
0 |
- |
|
HGSI |
Human Genome Sciences Inc |
Director |
|
2010-04-12 |
4 |
A |
$32.86 |
$13,998 |
D/D |
426 |
28,662 |
0 |
- |
|
HGSI |
Human Genome Sciences Inc |
Director |
|
2010-07-12 |
4 |
A |
$25.23 |
$25,733 |
D/D |
951 |
29,613 |
0 |
- |
|
HGSI |
Human Genome Sciences Inc |
Director |
|
2010-10-11 |
4 |
A |
$29.15 |
$17,140 |
D/D |
588 |
30,201 |
0 |
- |
|
HGSI |
Human Genome Sciences Inc |
Director |
|
2011-01-10 |
4 |
A |
$25.83 |
$23,738 |
D/D |
919 |
31,120 |
0 |
- |
|
HGSI |
Human Genome Sciences Inc |
Director |
|
2011-04-10 |
4 |
A |
$28.74 |
$23,739 |
D/D |
826 |
31,946 |
0 |
- |
|
HGSI |
Human Genome Sciences Inc |
Director |
|
2011-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
34,446 |
0 |
- |
|
HGSI |
Human Genome Sciences Inc |
Director |
|
2011-07-10 |
4 |
A |
$24.52 |
$17,998 |
D/D |
734 |
35,180 |
0 |
- |
|
RDYN |
Replidyne Inc |
Director |
|
2011-08-08 |
4 |
A |
$0.00 |
$0 |
D/D |
3,596 |
3,596 |
0 |
- |
|
HGSI |
Human Genome Sciences Inc |
Director |
|
2011-10-10 |
4 |
A |
$11.13 |
$18,242 |
D/D |
1,639 |
36,819 |
0 |
- |
|
81 Records found
|
|
Page 1 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|